SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neuroscience -- Ignore unavailable to you. Want to Upgrade?


To: Nikole Wollerstein who wrote (123)11/2/2000 12:21:18 AM
From: Marty  Respond to of 278
 
Nikita, would it be wrong to conclude that this announcement would be good news for Neotrofin because it serves to shed more light and confirmation on the presumed mechanism of action while it is three years ahead in clinical trials?



To: Nikole Wollerstein who wrote (123)11/2/2000 12:41:36 PM
From: Marty  Read Replies (1) | Respond to of 278
 
This abstract is a bit too deep for me but it may help the scientists on the thread with their conjecturing and hypothesizing about Neotrofin.

bio.davidson.edu